Importer of Controlled Substances Registration, 66752 [2018-28076]
Download as PDF
<![CDATA[
66752
Federal Register / Vol. 83, No. 247 / Thursday, December 27, 2018 / Notices
This company plans to import the
listed controlled substances in bulk
form for testing and calibration only.
The listed controlled substances are not
for human or animal use.
Dated: December 8, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–28076 Filed 12–26–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
[FR Doc. 2018–28080 Filed 12–26–18; 8:45 am]
BILLING CODE 4410–09–P
Employee Benefits Security
Administration
DEPARTMENT OF JUSTICE
Exemptions from Certain Prohibited
Transaction Restrictions
Drug Enforcement Administration
AGENCY:
Employee Benefits Security
Administration, Labor.
ACTION: Grants of Individual
Exemptions.
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as an importer of
schedule I or schedule II controlled
substances.
SUPPLEMENTARY INFORMATION:
The company listed below applied to
be registered as an importer of various
basic classes of controlled substances.
Information on the previously published
notice is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for this notice.
Company: Fisher Clinical Services,
Inc.
FR Docket: 83 FR 53108.
Published: October 19, 2018.
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrant to import the applicable
basic classes of schedule I or II
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I controlled substance to the
above listed company.
VerDate Sep<11>2014
17:14 Dec 26, 2018
Jkt 247001
This document contains
exemptions issued by the Department of
Labor (the Department) from certain of
the prohibited transaction restrictions of
the Employee Retirement Income
Security Act of 1974 (ERISA or the Act)
and/or the Internal Revenue Code of
1986 (the Code). This notice includes
the following: 2018–08, Liberty Media
401(k) Savings Plan, D–11890; and
2018–09, CLS Investments, LLC and
Affiliates, D–11931.
SUPPLEMENTARY INFORMATION: Notices
were published in the Federal Register
of the pendency before the Department
of proposals to grant such exemptions.
Each notice set forth a summary of the
facts and representations made by the
applicant for the exemption, and
referred interested persons to the
application for a complete statement of
the facts and representations. Each
application is available for public
inspection at the Department in
Washington, DC Each notice also
invited interested persons to submit
comments on the requested exemption
to the Department. In addition, each
notice stated that any interested person
might submit a written request that a
public hearing be held (where
appropriate). Each applicant has
represented that it has complied with
the requirements of the notification to
interested persons. No requests for a
hearing were received by the
Department. Public comments were
received by the Department as described
in the granted exemption.
Each notice of proposed exemption
was issued, and each exemption is being
granted, solely by the Department,
because, effective December 31, 1978,
section 102 of Reorganization Plan No.
4 of 1978, 5 U.S.C. App. 1 (1996),
transferred the authority of the Secretary
of the Treasury to issue exemptions of
the type proposed to the Secretary of
Labor.
SUMMARY:
SUMMARY:
khammond on DSK30JT082PROD with NOTICES
Dated: December 8, 2018.
John J. Martin,
Assistant Administrator.
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
Statutory Findings
In accordance with section 408(a) of
the Act and/or section 4975(c)(2) of the
Code and the procedures set forth in 29
CFR part 2570, subpart B (76 FR 66637,
66644, October 27, 2011) and based
upon the entire record, the Department
makes the following findings:
(a) Each exemption is
administratively feasible;
(b) Each exemption is in the interests
of the plan and its participants and
beneficiaries; and
(c) Each exemption is protective of the
rights of the participants and
beneficiaries of the plan.
Liberty Media 401(k) Savings Plan (the
Plan) Located in Englewood, CO
[Prohibited Transaction Exemption 2018–08;
Exemption Application No. D–11890]
Written Comments
In the Notice of Proposed Exemption
published in the Federal Register on
April 4, 2018 at 83 FR 14505 (the
Notice), the Department invited all
interested persons to submit written
comments and requests for a hearing
within thirty-seven (37) days of the date
of the publication. All comments and
requests for a hearing were due by May
11, 2018.
During the comment period, the
Department received no comments and
no requests for a public hearing.
After full consideration and review of
the entire record, the Department has
determined to grant the exemption, as
set forth above. The complete
application file (D–11890) is available
for public inspection in the Public
Disclosure Room of the Employee
Benefits Security Administration, Room
N–1513, U.S. Department of Labor, 200
Constitution Avenue NW, Washington
DC 20210.
For a more complete statement of the
facts and representations supporting the
Department’s decision to grant this
exemption refer to the Notice published
on April 4, 2018 at 83 FR 14505.
Exemption
Section I. Transactions
Effective for the period beginning May
24, 2016, and ending June 16, 2016, the
restrictions of sections 406(a)(1)(E),
406(a)(2), and 407(a)(1)(A) of the Act 1
shall not apply to:
(a) The acquisition by the Plan of
certain stock subscription rights (the
Rights) to purchase shares of Series C
Liberty Braves common stock (the Series
1 For purposes of this exemption, references to
specific provisions of Title I of the Act, unless
otherwise specified, should be read to refer as well
to the corresponding provisions of the Code.
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 83, Number 247 (Thursday, December 27, 2018)]
[Notices]
[Page 66752]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-28076]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrant listed below has applied for and been granted
registration by the Drug Enforcement Administration (DEA) as an
importer of schedule I or schedule II controlled substances.
SUPPLEMENTARY INFORMATION:
The company listed below applied to be registered as an importer of
various basic classes of controlled substances. Information on the
previously published notice is listed in the table below. No comments
or objections were submitted and no requests for hearing were submitted
for this notice.
Company: Fisher Clinical Services, Inc.
FR Docket: 83 FR 53108.
Published: October 19, 2018.
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrant to
import the applicable basic classes of schedule I or II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated the company's
maintenance of effective controls against diversion by inspecting and
testing the company's physical security systems, verifying the
company's compliance with state and local laws, and reviewing the
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I controlled substance to the above listed
company.
Dated: December 8, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-28076 Filed 12-26-18; 8:45 am]
BILLING CODE 4410-09-P
